Radiolabeling of magnetic targeted carriers (MTC) with indium-111

被引:10
|
作者
Häfeli, UO
Yu, JF
Farudi, F
Li, YH
Tapolsky, G
机构
[1] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA
[2] Chinese Acad Sci, Shanghai Inst Nucl Res, Shanghai 201800, Peoples R China
[3] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
[4] FeRx Inc, Aurora, CO 80010 USA
关键词
magnetic targeting; microspheres; radiolabeling; indium-111; yttrium-90; imaging;
D O I
10.1016/S0969-8051(03)00077-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Magnetic targeted carriers (MTC) are magnetically susceptible microparticles that can be physically targeted to a specific site. MTC were radiolabeled with In-111 using three different methods. Reaction parameters were investigated in order to optimize the final properties of the labeled MTC. The reaction parameters studied were chelation agent, chelation time, temperature, radiolabeling time, solvent, and molar ratios. A 97.7 +/- 0.9% binding efficiency and plasma stability of 92.6 +/- 0.1% over 7 days were achieved when 2-p-aminobenzyl-1,4,7, 10-tetraazacyclododecane-1,4,7,10-tetra-acetic acid (ABz-DOTA) was used as the chelating agent. A preliminary animal biodistribution study confirmed the binding stability. The labeling of the MTC with the diagnostic isotope In-111 was undertaken to allow for quantitative imaging and dosimetry prior to therapy with Y-90 radiolabeled MTC. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 50 条
  • [31] Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases
    Guitera-Rovel, P
    Lumbroso, J
    Gautier-Gougis, MS
    Spatz, A
    Mercier, S
    Margulis, A
    Mamelle, G
    Kolb, F
    Lartigau, E
    Avril, MF
    ANNALS OF ONCOLOGY, 2001, 12 (06) : 807 - 811
  • [32] Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities
    Inanir, Sabahat
    Ünlü, Mustafa
    Okudan, Berna
    Cila, Erdal
    Atik, Sahap
    European Journal of Nuclear Medicine and Molecular Imaging, 1996, 23 (08) : 987 - 990
  • [33] Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities
    Inanir, S
    Unlu, M
    Okudan, B
    Cila, E
    Atik, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (08): : 987 - 990
  • [34] CONJUGATION OF ANTIBODIES WITH COMPOUNDS CAPABLE OF RAPIDLY BINDING INDIUM-111
    PRITCHARD, JH
    ACKERMAN, MJ
    TUBIS, M
    BLAHD, WH
    JOURNAL OF NUCLEAR MEDICINE, 1975, 16 (06) : 559 - 559
  • [35] Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia
    Nguyen, BD
    Wang, EA
    CLINICAL NUCLEAR MEDICINE, 1999, 24 (02) : 130 - 131
  • [36] CURRENT STATUS OF INDIUM-111 LABELED BLEOMYCIN FOR TUMOR DETECTION
    TAYLOR, RD
    BLAHD, WH
    WESTERN JOURNAL OF MEDICINE, 1975, 123 (05): : 386 - 386
  • [37] Indium-111 labelled lymphocytes: isotope distribution and cell division
    J. Kuyama
    A. McCormack
    A. J. T. George
    B. T. Heelan
    S. Osman
    J. R. Batchelor
    A. M. Peters
    European Journal of Nuclear Medicine, 1997, 24 (5) : 488 - 496
  • [38] Indium-111 pentetreotide lung uptake in infectious lung disease
    Castellani, M
    Reschini, E
    Gasparini, M
    Gerundini, P
    CLINICAL NUCLEAR MEDICINE, 1999, 24 (05) : 343 - 345
  • [39] Indium-111 white blood cell localization in a barium concretion
    Reiter, MP
    Silverman, ED
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (01) : 53 - 55
  • [40] Intraoperative detection of lung cancer by octreotide labeled to indium-111
    Pastore, V
    Di Lieto, E
    Mansi, L
    Rambaldi, PF
    Santini, M
    Mancusi, R
    SEMINARS IN SURGICAL ONCOLOGY, 1998, 15 (04): : 220 - 222